London Escorts sunderland escorts asyabahis.org dumanbet.live pinbahiscasino.com www.sekabet.net olabahisgir.com maltcasino.net faffbet-giris.com asyabahisgo1.com dumanbetyenigiris.com pinbahisgo1.com sekabet-giris2.com www.olabahisgo.com maltcasino-giris.com www.faffbet.net www.betforward1.org betforward.mobi www.1xbet-adres.com 1xbet4iran.com www.romabet1.com www.yasbet2.net www.1xirani.com romabet.top www.3btforward1.com 1xbet 1xbet-farsi4.com بهترین سایت شرط بندی بت فوروارد

Complete round a financing of 20 million yuan! TEDA Biomedical enterprises accelerate the layout of high-end blood purification projects

Tianjin North network news: recently, Tianjin younas Biotechnology Co., Ltd. (hereinafter referred to as “younas”), an enterprise in Tianjin Economic Development Zone, completed a round of financing of RMB 20 million, which will be used to accelerate the layout of high-end blood purification market projects. Up to now, the project has invested 150 million yuan.

The current round of financing of Yunus will be mainly used to promote the clinical transformation of blood purification products related to Yunus artificial kidney and artificial liver support system, accelerate the research and development progress of technologies related to viruses, tumors, metabolic diseases and immune diseases, as well as the transformation of GMP plant and the construction of talent echelon, strengthen external business cooperation and supplement working capital. The investor of this round of financing is Zhongke Haichuang, which is the venture capital sub fund of the national scientific and technological achievement transformation guidance fund. It is a national professional equity investment institution, focusing on investing in unlisted high-tech enterprises.

Yunus was established in Tianjin Economic Development Zone in 2013. The company was jointly established by the founding team and Nankai University. It is committed to the R & D, production and sales of blood purification and treatment products for major and difficult human diseases. Ou Lailiang, the founder and chairman of the company, is the chief scientist of the national key R & D plan. He has been engaged in the systematic research and development of blood purification materials and engineering for a long time, and has been successively selected as a member of the innovation team of Tianjin entrepreneurship leading talents and innovative talents promotion plan. Inheriting the traditional advantages of Nankai University in the field of blood purification research, the company has created a series of internationally leading products related to blood purification materials by using the method of material genomics, and solved the “neck sticking” problem of a number of blood purification technologies. (Jin Yun news reporter Chen runing)

- Advertisment -